Nicole Lambert - 09 Oct 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Signature: By: Nathan A. Smith For: Nicole Lambert
Issuer symbol: MYGN
Transactions as of: 09 Oct 2021
Net transactions value: -$385,475
Form type: 4
Filing time: 12 Oct 2021, 16:46:00 UTC
Previous filing: 04 Oct 2021
Next filing: 10 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Tax liability	$154,801	-5,013	-2.8%	$30.88	171,639	09 Oct 2021	Direct	F1
transaction	MYGN	Common Stock	Tax liability	$230,674	-7,470	-4.4%	$30.88	164,169	09 Oct 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.
F2	Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

Remarks:

Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.